Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Targeting cardiac fibrosis with engineered T cells

Open access

Abstract

Fibrosis is observed in nearly every form of myocardial disease 1. Upon injury, cardiac fibroblasts in the heart begin to remodel the myocardium by depositing excess extracellular matrix, resulting in increased stiffness and reduced compliance of the tissue. Excessive cardiac fibrosis is an important factor in the progression of various forms of cardiac disease and heart failure 2. However, clinical interventions and therapies that target fibrosis remain limited 3. Here we demonstrate the efficacy of redirected T cell immunotherapy to specifically target pathological cardiac fibrosis in mice. We find that cardiac fibroblasts that express a xenogeneic antigen can be effectively targeted and ablated by adoptive transfer of antigen-specific CD8+ T cells. Through expression analysis of the gene signatures of cardiac fibroblasts obtained from healthy and diseased human hearts, we identify an endogenous target of cardiac fibroblasts-fibroblast activation protein. Adoptive transfer of T cells that express a chimeric antigen receptor against fibroblast activation protein results in a significant reduction in cardiac fibrosis and restoration of function after injury in mice. These results provide proof-of-principle for the development of immunotherapeutic drugs for the treatment of cardiac disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-019-1546-z

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 825

Metadata

Authors
Aghajanian, H., Kimura, T., Rurik, J. G., Hancock, A. S., Leibowitz, M. S., Li, L., Scholler, J., Monslow, J., Lo, A., Han, W., Wang, T., Bedi, K., Morley, M. P., Linares Saldana, R. A., Bolar, N. A., McDaid, K., Assenmacher, C.-A., Smith, C. L., Wirth, D., June, C. H., Margulies, K. B., Jain, R., Puré, E., Albelda, S. M., & Epstein, J. A.
Affiliations
  • University of Pennsylvania (US)
  • Children's Hospital of Philadelphia (US)
  • Hospital of the University of Pennsylvania (US)
  • Helmholtz Centre for Infection Research (DE)
Corresponding author
Epstein, Jonathan A.
Venue
Nature
Published
2019-09-11
Volume
573
Issue
7774
Pages
430-433
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2972517993
Cited by
801
References
45
Citations by year
2026: 109 · 2025: 156 · 2024: 143 · 2023: 97 · 2022: 136 · 2021: 84 · 2020: 64 · 2019: 10
FWCI
53.09
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • HZI (Helmholtz Centre for Infection Research) (submittedVersion, cc-by-nc-sa)
Funders
  • National Institutes of Health (1s10od023465-01a1)
  • National Heart, Lung, and Blood Institute (R01HL139783, F31HL147416, T32HL007843, R35HL140018)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK019525)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR053461)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
  • Health Sciences › Medicine › Oncology › CAR-T cell therapy research
Keywords
myocardial fibrosis, chimeric antigen receptor T cells, fibroblast activation protein, cardiac fibroblasts, chimeric antigen receptor, adoptive T cell therapy, heart failure, cardiac injury, extracellular matrix deposition, immunotherapy
MeSH terms
Animals, Antigens, Surface, Endomyocardial Fibrosis, Fibroblasts, Humans, Male, Ovalbumin, Wound Healing, Immunotherapy, Adoptive, CD8-Positive T-Lymphocytes, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting cardiac fibrosis with engineered T cells. https://app.cochat.ai/papers/10.1038/s41586-019-1546-z
The paper
Aghajanian, H., Kimura, T., Rurik, J. G., Hancock, A. S., Leibowitz, M. S., Li, L., Scholler, J., Monslow, J., Lo, A., Han, W., Wang, T., Bedi, K., Morley, M. P., Linares Saldana, R. A., Bolar, N. A., McDaid, K., Assenmacher, C.-A., Smith, C. L., Wirth, D., . . . Epstein, J. A. (2019). Targeting cardiac fibrosis with engineered T cells. Nature. https://doi.org/10.1038/s41586-019-1546-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.